Articles

Summit discusses innovating Life Sciences for a sustainable future and creates a platform for dialogue, knowledge exchange and partnership.

Healthcare systems face increasing pressure to reduce their environmental footprint. Meeting regulatory demands and satisfying stakeholder expectations are just a few of the driving forces. Product Environmental Profiles (PEP) are becoming a powerful tool, providing transparent, reliable data on a product’s environmental performance. Based on comprehensive life cycle assessments, PEPs help hospitals make informed, sustainable purchasing decisions that support both environmental responsibility and financial performance.

In pharmaceutical production, maintaining equipment uptime is essential for operational efficiency and process safety. Particularly in cleanroom environments, unplanned downtime can disrupt workflows, increase overhead costs, and in some cases contribute to delays in drug availability.

In the ever-evolving landscape of medical technology, ensuring the safety and performance of surgical equipment is paramount. The IEC 60601-2-41:2021 (Edition 3) standard sets forth the particular requirements for the basic safety and essential performance of surgical luminaires and luminaires for diagnosis.

Modern operating rooms are high-stakes environments where every minute counts. An unexpected issue with critical equipment like the operating table can disrupt schedules and even jeopardize patient safety.

During sterile manufacturing, human operators pose the greatest risk for product contamination. To reduce microbiological and particulate contamination risks, aseptic techniques typically rely on either laminar flow equipment used within a cleanroom environment or barrier technology. Laminar flow equipment includes laminar flow hoods and biosafety cabinets (Class I, Class II, and Class III). Barrier technology includes restricted access barrier systems (RABS) and isolators.

Aragen’s goal was to see if their production process could be easily scaled up to larger, single-use bioreactors. Learn more about their findings.

Facing the dual challenge of boosting efficiency and reducing strain of staff, a leading sterilization provider in Japan has digitalized their sterile reprocessing.

Explore the future of pharmaceutical manufacturing with 4 key trends in sterile component transfer. From pre-validated solutions to manufacturing flexibility and increased automation, discover how industry leaders Getinge and West are shaping the landscape.

Discover how our DPTE® rapid transfer port, tested in collaboration with SafeBridge® Regulatory & Life Sciences Group, ensures personnel and environmental safety in pharmaceutical manufacturing facilities. Read the assessment of containment performance, validating the effectiveness of the DPTE® Alpha port against potentially hazardous active pharmaceutical ingredients.

The pharmaceutical industry constantly seeks innovations that enhance the safety, efficiency, and precision of drug production. One such revolutionary technology that has significantly impacted the industry is the DPTE® system, introduced in the 1960s. This article explores the history and evolution of DPTE®, highlighting its pivotal role in pharmaceutical production and the extensive experience that Getinge brings to the table after 60 years in the field.

A new pre-validated wash rack, enabling the staff at Fujirebio to create a standardized cleaning process of multi-use bioreactors which saves time in their important work to produce more antibodies used in cancer diagnostics.